Online Program Home
  My Program

All Times EDT

Legend:
* = applied session       ! = JSM meeting theme

Activity Details

343 Wed, 8/5/2020, 10:00 AM - 2:00 PM Virtual
Longitudinal Analysis, Clinical Trial Design, and Other Topics in Biopharmaceutical Statistics — Contributed Papers
Biopharmaceutical Section
Chair(s): Yanping Liu, Merck
A Flexible Framework to Estimate the Impact of Preplanned Dose Titrations on Delayed Response
Yu Du, Eli Lilly and Company; Yongming Qu, Eli Lilly and Company
Predicted Response Rate Differences of Antidepressants at End Point Among Patients Not Meeting Study Early Response
Marc Sobel, temple university; Ibrahim Turkoz, Janssen Research and Development, LLC; Xiwu Lin, Janssen Research and Development, LLC; Ella Daly, Janssen Scientific Affairs LLC
Exploring Heterogeneity of Treatment Response: Longitudinal Aspect
Lev Sverdlov, Redmond Analytics, LLC
Modeling Considerations in a Dose-Finding Study for a Rare Disease Treatment
Younan Chen, CSL Behring; Sergei Leonov, CSL Behring; Michael Fries, CSL Behring
A Statistical Evaluation of Agreement Between Mobile Health Technology and Traditional Tools
Qinlei Huang, Merck & Co., Inc; Radha Railkar, Merck & Co., Inc.
Estimating Knots in Bilinear Spline Growth Mixture Models with Time-Invariant Covariates in the Framework of Individual Measurement Occasions
Jin Liu; Robert A Perera, Virginia Commonwealth University Dept of Biostatistics; Le Kang, Virginia Commonwealth University; Roy T Sabo, Virginia Commonwealth University